Perspective Articles

Myelodysplastic syndrome patient-derived xenografts: from no options to many

The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark
The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark
Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK
The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark;Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark
Vol. 105 No. 4 (2020): April, 2020 https://doi.org/10.3324/haematol.2019.233320